Back to
UBS Group AG
SRPT29 quarters
Position history for
UBS Group AG's holdings in SAREPTA THERAPEUTICS INC
UBS Group AG holds 2.2M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $48.6M as of 2026-Q1. The position was increased (+8.4% shares). SRPT represents 0.0% of UBS Group AG's portfolio.
Current Value
$48.6M
Current Shares
2.2M
Total Value Change
+$39M
Total Shares Change
+2.2M
Quarter-by-Quarter History
Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC